ArcherDx's Acquisition - II

ArcherDx raised a round of funding on June 22, 2020. Investors include Invitae.

ArcherDX offers a bioinformatics platform for targeted sequencing applications featuring proprietary Anchored Multiplexed PCR (AMP) chemistry in a lyophilized format. On June 22nd, 2020, ArcherDx was…

Articles about ArcherDx's Acquisition - II: